data_1amb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1amb _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 12.0 t70 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.495 -0.557 . . . . 3.3900000000000001 109.495 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 6' ' ' HIS . . . -60.3 -63.24 1.37 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.266 -0.896 . . . . 1.4299999999999999 109.48 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.492 ' HG3' ' N ' ' A' ' 4' ' ' PHE . 8.9 pt-20 -53.84 -31.67 50.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -0.893 . . . . 2.1899999999999999 109.936 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.492 ' N ' ' HG3' ' A' ' 3' ' ' GLU . 0.1 OUTLIER -61.29 -66.44 0.53 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.272 -0.893 . . . . 2.79 109.71 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -68.3 -7.68 33.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -0.906 . . . . 4.4199999999999999 109.749 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.473 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 4.7 t60 -76.41 -70.06 0.47 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.738 -0.838 . . . . 1.51 108.738 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.401 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 4.4 m-20 -55.35 -41.15 72.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.399 -0.813 . . . . 2.2599999999999998 109.129 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.2 t -54.52 -62.91 1.35 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 1.5700000000000001 109.12 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 13' ' ' HIS . . . -69.17 -6.72 54.78 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.391 -1.484 . . . . 0.47999999999999998 109.391 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.473 ' HB2' ' O ' ' A' ' 6' ' ' HIS . 16.4 t80 -72.32 -59.98 2.46 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.228 -1.16 . . . . 2.27 109.857 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.58 ' O ' ' ND1' ' A' ' 14' ' ' HIS . 5.2 mt-10 -72.18 -39.73 68.45 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.832 -1.173 . . . . 1.99 107.832 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.436 ' HA ' ' HB2' ' A' ' 15' ' ' GLN . 8.8 t -59.77 -35.68 61.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.018 -1.104 . . . . 1.1299999999999999 108.018 178.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.471 ' C ' ' CD2' ' A' ' 13' ' ' HIS . 5.9 t60 -55.06 -56.97 13.78 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 105.897 -1.89 . . . . 0.66000000000000003 105.897 176.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.639 ' CE1' ' NE2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -50.28 -30.06 11.05 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.362 -0.977 . . . . 0.44 108.362 178.515 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.639 ' NE2' ' CE1' ' A' ' 14' ' ' HIS . 0.0 OUTLIER -64.38 -48.52 75.14 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.465 -0.772 . . . . 0.48999999999999999 109.711 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.428 ' C ' ' HD2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -64.4 -46.0 85.19 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.584 -0.697 . . . . 2.0499999999999998 110.073 -179.551 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.34 -30.43 71.47 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.148 -0.97 . . . . 1.47 109.894 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.475 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 18.6 t -78.35 -29.59 15.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.174 -0.954 . . . . 1.1499999999999999 108.668 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -72.7 -33.17 66.3 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.859 -0.793 . . . . 2.3999999999999999 108.859 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.58 ' CD2' HG22 ' A' ' 24' ' ' VAL . 3.1 t80 -74.78 -41.26 60.34 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.537 -0.727 . . . . 2.3799999999999999 109.198 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.511 ' O ' ' HA3' ' A' ' 25' ' ' GLY . . . -71.54 -25.51 62.25 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.772 -1.205 . . . . 1.1100000000000001 109.563 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.563 ' O ' ' CB ' ' A' ' 26' ' ' SER . 1.3 mt-10 -76.05 -43.51 43.55 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.975 -1.078 . . . . 2.02 108.656 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.07 -65.98 0.94 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.571 -1.27 . . . . 1.23 107.571 178.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.58 HG22 ' CD2' ' A' ' 20' ' ' PHE . 20.5 t -52.68 -45.69 48.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-O 121.478 0.656 . . . . 1.1699999999999999 109.833 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 21' ' ' ALA . . . -69.3 -44.74 64.08 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 108.918 -1.673 . . . . 0.57999999999999996 108.918 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.563 ' CB ' ' O ' ' A' ' 22' ' ' GLU . 2.5 t -44.81 -50.86 10.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.314 -1.109 . . . . 1.6299999999999999 109.105 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.417 ' OD1' ' C ' ' A' ' 27' ' ' ASN . 47.9 p-10 -108.32 51.47 0.74 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.358 -0.839 . . . . 1.6799999999999999 109.426 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.519 ' CG ' ' O ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.024 -0.989 . . . . 3.4399999999999999 109.501 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 12.0 t70 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.495 -0.557 . . . . 3.39 109.495 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 6' ' ' HIS . . . -60.3 -63.24 1.37 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.266 -0.896 . . . . 0.94 109.48 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.5 ' HG3' ' N ' ' A' ' 4' ' ' PHE . 8.9 pt-20 -53.84 -31.67 50.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -0.893 . . . . 2.19 109.936 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.5 ' N ' ' HG3' ' A' ' 3' ' ' GLU . 0.1 OUTLIER -61.29 -66.44 0.53 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.272 -0.893 . . . . 2.02 109.71 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -68.3 -7.68 33.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -0.906 . . . . 3.8 109.749 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.48 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 4.7 t60 -76.41 -70.06 0.47 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.738 -0.838 . . . . 1.19 108.738 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.426 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 4.4 m-20 -55.35 -41.15 72.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.399 -0.813 . . . . 2.26 109.129 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.2 t -54.52 -62.91 1.35 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 1.14 109.12 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 13' ' ' HIS . . . -69.17 -6.72 54.78 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.391 -1.484 . . . . 0.48 109.391 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.48 ' HB2' ' O ' ' A' ' 6' ' ' HIS . 16.4 t80 -72.32 -59.98 2.46 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.228 -1.16 . . . . 1.39 109.857 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.58 ' O ' ' ND1' ' A' ' 14' ' ' HIS . 5.2 mt-10 -72.18 -39.73 68.45 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.832 -1.173 . . . . 1.99 107.832 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.466 ' HA ' ' HB2' ' A' ' 15' ' ' GLN . 8.8 t -59.77 -35.68 61.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.018 -1.104 . . . . 0.45 108.018 178.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.48 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 6.5 t-80 -55.06 -56.97 13.78 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 105.897 -1.89 . . . . 0.61 105.897 176.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.58 ' ND1' ' O ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -50.28 -30.06 11.05 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.362 -0.977 . . . . 0.42 108.362 178.515 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.489 ' OE1' ' CE1' ' A' ' 14' ' ' HIS . 0.8 OUTLIER -64.38 -48.52 75.14 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.465 -0.772 . . . . 0.49 109.711 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.416 ' C ' ' HD2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -64.4 -46.0 85.19 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.584 -0.697 . . . . 1.56 110.073 -179.551 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 17' ' ' LEU . 0.1 OUTLIER -64.34 -30.43 71.47 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.148 -0.97 . . . . 0.81 109.894 -179.497 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.49 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 18.6 t -78.35 -29.59 15.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.174 -0.954 . . . . 0.42 108.668 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -72.7 -33.17 66.3 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.859 -0.793 . . . . 1.53 108.859 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.995 ' CE2' HG21 ' A' ' 24' ' ' VAL . 3.1 t80 -74.78 -41.26 60.34 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.537 -0.727 . . . . 1.52 109.198 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.496 ' O ' ' HA3' ' A' ' 25' ' ' GLY . . . -71.54 -25.51 62.25 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.772 -1.205 . . . . 0.35 109.563 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.563 ' O ' ' CB ' ' A' ' 26' ' ' SER . 1.3 mt-10 -76.05 -43.51 43.55 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.975 -1.078 . . . . 2.02 108.656 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.07 -65.98 0.94 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.571 -1.27 . . . . 1.23 107.571 178.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.995 HG21 ' CE2' ' A' ' 20' ' ' PHE . 20.5 t -52.68 -45.69 48.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-O 121.478 0.656 . . . . 0.53 109.833 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 21' ' ' ALA . . . -69.3 -44.74 64.08 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 108.918 -1.673 . . . . 0.58 108.918 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.563 ' CB ' ' O ' ' A' ' 22' ' ' GLU . 2.5 t -44.81 -50.86 10.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.314 -1.109 . . . . 1.32 109.105 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.417 ' OD1' ' C ' ' A' ' 27' ' ' ASN . 47.9 p-10 -108.32 51.47 0.74 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.358 -0.839 . . . . 1.68 109.426 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.519 ' CG ' ' O ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.024 -0.989 . . . . 3.06 109.501 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 12.0 t70 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.495 -0.557 . . . . 3.3900000000000001 109.495 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 6' ' ' HIS . . . -60.3 -63.24 1.37 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.266 -0.896 . . . . 0.93999999999999995 109.48 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.5 ' HG3' ' N ' ' A' ' 4' ' ' PHE . 8.9 pt-20 -53.84 -31.67 50.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -0.893 . . . . 2.1899999999999999 109.936 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.5 ' N ' ' HG3' ' A' ' 3' ' ' GLU . 0.1 OUTLIER -61.29 -66.44 0.53 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.272 -0.893 . . . . 2.02 109.71 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -68.3 -7.68 33.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -0.906 . . . . 3.7999999999999998 109.749 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.48 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 4.7 t60 -76.41 -70.06 0.47 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.738 -0.838 . . . . 1.1899999999999999 108.738 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.426 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 4.4 m-20 -55.35 -41.15 72.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.399 -0.813 . . . . 2.2599999999999998 109.129 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.2 t -54.52 -62.91 1.35 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 1.1399999999999999 109.12 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 13' ' ' HIS . . . -69.17 -6.72 54.78 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.391 -1.484 . . . . 0.47999999999999998 109.391 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.48 ' HB2' ' O ' ' A' ' 6' ' ' HIS . 16.4 t80 -72.32 -59.98 2.46 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.228 -1.16 . . . . 1.3899999999999999 109.857 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.58 ' O ' ' ND1' ' A' ' 14' ' ' HIS . 5.2 mt-10 -72.18 -39.73 68.45 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.832 -1.173 . . . . 1.99 107.832 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.466 ' HA ' ' HB2' ' A' ' 15' ' ' GLN . 8.8 t -59.77 -35.68 61.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.018 -1.104 . . . . 0.45000000000000001 108.018 178.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.48 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 5.9 t60 -55.06 -56.97 13.78 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 105.897 -1.89 . . . . 0.60999999999999999 105.897 176.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.639 ' CE1' ' NE2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -50.28 -30.06 11.05 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.362 -0.977 . . . . 0.41999999999999998 108.362 178.515 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.639 ' NE2' ' CE1' ' A' ' 14' ' ' HIS . 0.0 OUTLIER -64.38 -48.52 75.14 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.465 -0.772 . . . . 0.48999999999999999 109.711 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.416 ' C ' ' HD2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -64.4 -46.0 85.19 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.584 -0.697 . . . . 1.5600000000000001 110.073 -179.551 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.419 ' HA ' HD13 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -64.34 -30.43 71.47 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.148 -0.97 . . . . 0.81000000000000005 109.894 -179.497 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.49 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 18.6 t -78.35 -29.59 15.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.174 -0.954 . . . . 0.41999999999999998 108.668 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -72.7 -33.17 66.3 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.859 -0.793 . . . . 1.53 108.859 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.995 ' CE2' HG21 ' A' ' 24' ' ' VAL . 3.1 t80 -74.78 -41.26 60.34 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.537 -0.727 . . . . 1.52 109.198 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.496 ' O ' ' HA3' ' A' ' 25' ' ' GLY . . . -71.54 -25.51 62.25 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.772 -1.205 . . . . 0.34999999999999998 109.563 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.563 ' O ' ' CB ' ' A' ' 26' ' ' SER . 1.3 mt-10 -76.05 -43.51 43.55 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.975 -1.078 . . . . 2.02 108.656 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.07 -65.98 0.94 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.571 -1.27 . . . . 1.23 107.571 178.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.995 HG21 ' CE2' ' A' ' 20' ' ' PHE . 20.5 t -52.68 -45.69 48.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-O 121.478 0.656 . . . . 0.53000000000000003 109.833 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 21' ' ' ALA . . . -69.3 -44.74 64.08 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 108.918 -1.673 . . . . 0.57999999999999996 108.918 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.563 ' CB ' ' O ' ' A' ' 22' ' ' GLU . 2.5 t -44.81 -50.86 10.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.314 -1.109 . . . . 1.3200000000000001 109.105 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.417 ' OD1' ' C ' ' A' ' 27' ' ' ASN . 47.9 p-10 -108.32 51.47 0.74 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.358 -0.839 . . . . 1.6799999999999999 109.426 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.519 ' CG ' ' O ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.024 -0.989 . . . . 3.0600000000000001 109.501 -179.9 . . . . . . . . 2 2 . 1 stop_ save_